European Head and Neck Cancer Therapeutics: Market Forecast and...

added blog Other

2025-12-10 13:14:47 -

European Head and Neck Cancer Therapeutics: Market Forecast and Strategic Insights 2025–2035

The European head and neck cancer (HNC) therapeutics market is entering a transformative decade, driven by rising cancer incidence, accelerated adoption of immunotherapy, and a strengthening pipeline of targeted and next-generation biologics. The market was valued at USD 749.2 million in 2024, and it is projected to reach USD 2.1 billion by 2035, expanding at a CAGR of...

0 Comments 0 Shares 112 Views